No Independent Link for Maternal Pot Use, Neonatal Outcomes

Share this content:
No Independent Link for Maternal Pot Use, Neonatal Outcomes
No Independent Link for Maternal Pot Use, Neonatal Outcomes

WEDNESDAY, Sept. 14, 2016 (HealthDay News) -- Maternal marijuana use is not independently associated with adverse neonatal outcomes, according to a review published in the October issue of Obstetrics & Gynecology.

Shayna N. Conner, M.D., from Washington University in St. Louis, and colleagues extracted data from studies that compared rates of prespecified adverse neonatal outcomes in women who used marijuana during pregnancy and women who did not. The primary outcomes were low birth weight and preterm delivery at less than 37 weeks of gestation. Data were included from 31 studies that assessed the effects of marijuana use during pregnancy.

The researchers found that marijuana use during pregnancy was associated with an elevated risk of low birth weight (15.4 versus 10.4 percent; pooled relative risk, 1.43; 95 percent confidence interval, 1.27 to 1.62) and with preterm delivery (15.3 versus 9.6 percent; pooled relative risk, 1.32; 95 percent confidence interval, 1.14 to 1.54) based on pooled unadjusted data. After adjustment for tobacco use and other confounding factors, pooled data showed no statistically significant risk for low birth weight (pooled relative risk, 1.16; 95 percent confidence interval, 0.98 to 1.37) or for preterm delivery (pooled relative risk, 1.08; 95 percent confidence interval, 0.82 to 1.43).

"The association between maternal marijuana use and adverse outcomes appears attributable to concomitant tobacco use and other confounding factors," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Recent Decline in Prescription Opioid Use Among U.S. Teens

Recent Decline in Prescription Opioid Use Among U.S. ...

Lifetime prevalence of use peaked in 1989, 2002, and remained stable until decline in 2013 to 2015

Treatment Seeking Low Among Teens With Eating Disorders

Treatment Seeking Low Among Teens With Eating Disorders

Those with counter-stereotypic presentation even less likely to seek treatment

Optical Clearing Agent Ups No. of Laser Passes in Tattoo Removal

Optical Clearing Agent Ups No. of Laser Passes ...

Findings based on number of laser passes during a five-minute tattoo removal session

is free, fast, and customized just for you!

Already a member?

Sign In Now »